Marlies C. van der Goes

Author

Also Known As

M C van der Goes, M. C. Van der Goes, M. C. van der Goes, M.C. Van der Goes, M.C. van der Goes, MARLIES C. van der GOES, Marlies C van der Goes, Marlies C. van der Goes

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University Meander Medisch Centrum Charité - Universitätsmedizin Berlin Hôpital Cochin

About

Marlies C. van der Goes is an author at University Medical Center Utrecht specializing in diagnosis, predictive analytics, and knowledge discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	1	1	13
2	Medicine	1	1	13
3	Data Science	1	1	13
4	Pharmacology	1	1	13
5	Data Mining	1	1	13

Marlies C. van der Goes

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
EULAR definition of difficult-to-treat rheumatoid arthritis György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Annals of the Rheumatic Diseases	2020	486
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases Nneoma Duru, Marlies C. van der Goes, J. W. G. Jacobs, Annals of the Rheumatic Diseases	2013	262
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Annals of the Rheumatic Diseases	2021	241
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice Marlies C. van der Goes, Johannes W. G. Jacobs, Maarten Boers, Annals of the Rheumatic Diseases	2010	187
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease Nadia M T Roodenrijs, Marlies C. van der Goes, Paco M J Welsing, Lara D. Veeken	2020	146
Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases Marlies C. van der Goes, J. W. G. Jacobs, Maarten Boers, Annals of the Rheumatic Diseases	2009	134
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey Nadia M T Roodenrijs, Maria J. H. de Hair, Marlies C. van der Goes, Annals of the Rheumatic Diseases	2018	128
Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids Jos N. Hoes, Marlies C. van der Goes, Daniël H. van Raalte, Annals of the Rheumatic Diseases	2011	112
Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied? Marlies C. van der Goes, Johannes W. G. Jacobs, M. S. Jurgens, Osteoporosis International	2012	58
Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study Nadia M T Roodenrijs, Paco M J Welsing, Marlies C. van der Goes, Lara D. Veeken	2021	42

Page 1